New Blood Cancer Treatment developed at Hadassah for Multiple Myeloma shows 90% improvement
BREAKING NEWS Hadassah together with Bar Ilan University have successfully developed an immunotherapy treatment for Multiple Myeloma by “reprogramming the immune systems” of cancer patients, with a US-based pharma company licensing it for commercialisation. The treatment involves removing healthy white blood cells — T-cells — from cancer patients and adding an artificial molecule before […]
